Literature DB >> 6327484

Etiology of fulminant viral hepatitis in Greece.

G Papaevangelou, N Tassopoulos, A Roumeliotou-Karayannis, C Richardson.   

Abstract

The etiology of fulminant viral hepatitis was determined in 65 consecutive cases among 1,814 (3.58%) adults with acute viral hepatitis who were admitted to the Infectious Diseases Hospital of Athens from May, 1981 to August, 1983. Radioimmunoassays were used to detect hepatitis B virus, hepatitis A virus and delta-agent markers. Enzyme immunoassay was used to detect anti-HBc IgM. Hepatitis B virus was responsible for 48 (73.9%), non-A, non-B for 16 (24.6%) and hepatitis A virus for one case (1.5%). The use of anti-HBc IgM identified 10 cases of fulminant type B hepatitis among HBsAg negative, anti-HBc and anti-HBs positive patients. Fulminant non-A, non-B hepatitis was superimposed on 10 asymptomatic HBsAg carriers; delta-agent co-infection was diagnosed in two fulminant type B hepatitis cases. These data show that hepatitis B virus is the major cause of fulminant hepatitis in Greece. HBsAg carriers are at high risk for fulminant non-A, non-B hepatitis. delta-agent does not seem to be as important as in Italy and other countries.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327484     DOI: 10.1002/hep.1840040304

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

Review 1.  Serological responses to HBV infection.

Authors:  E A Fagan; R Williams
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

2.  Viral superinfection in previously unrecognized chronic carriers of hepatitis B virus with superimposed acute fulminant versus nonfulminant hepatitis.

Authors:  C M Chu; C T Yeh; Y F Liaw
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

Review 3.  Epidemiology of chronic viral hepatitis in the Mediterranean area: present status and trends.

Authors:  G B Gaeta; G Giusti
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

4.  Interferon as treatment for acute hepatitis C. A meta-analysis.

Authors:  C Cammà; P Almasio; A Craxì
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 5.  Epidemiology of hepatitis A and B.

Authors:  G J Papaevangelou
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

6.  The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state.

Authors:  C M Chu; Y F Liaw
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

7.  Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus.

Authors:  C M Chu; C T Yeh; Y F Liaw
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

8.  Prediction of hepatic encephalopathy development in patients with severe acute hepatitis.

Authors:  Yasuhiro Takikawa; Ryujin Endo; Kazuyuki Suzuki; Kenji Fujiwara; Masao Omata
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

9.  Prospective assessment of incidence of fulminant hepatitis in post-transfusion hepatitis: a study of 504 cases.

Authors:  S Takano; M Omata; M Ohto; Y Satomura
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

Review 10.  Intensive liver care and management of acute hepatic failure.

Authors:  R Williams; A E Gimson
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.